SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001213900-20-001051
Filing Date
2020-01-15
Accepted
2020-01-15 11:41:32
Documents
9
Effectiveness Date
2020-01-15

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS dfan14a0120_alphaholdingsinc.htm DFAN14A 23263
2 GRAPHIC img_001.jpg GRAPHIC 272910
3 GRAPHIC img_002.jpg GRAPHIC 86791
4 GRAPHIC img_003.jpg GRAPHIC 173985
5 GRAPHIC img_004.jpg GRAPHIC 161840
6 GRAPHIC img_005.jpg GRAPHIC 161964
7 GRAPHIC img_006.jpg GRAPHIC 168432
8 GRAPHIC img_007.jpg GRAPHIC 198469
9 GRAPHIC img_008.jpg GRAPHIC 209027
  Complete submission text file 0001213900-20-001051.txt   1998416
Mailing Address 24 N. MAIN STREET PENNINGTON NJ 08534
Business Address 24 N. MAIN STREET PENNINGTON NJ 08534 (858) 210-7333
ONCOSEC MEDICAL Inc (Subject) CIK: 0001444307 (see all company filings)

IRS No.: 980573252 | State of Incorp.: NV | Fiscal Year End: 0731
Type: DFAN14A | Act: 34 | File No.: 000-54318 | Film No.: 20527715
SIC: 2834 Pharmaceutical Preparations

Mailing Address GANGNAM-GU APGUJEONG-RO 62-GIL 17-10 SEOUL M5 06016
Business Address GANGNAM-GU APGUJEONG-RO 62-GIL 17-10 SEOUL M5 06016 011-8225178841
Alpha Holdings, Inc. (Filed by) CIK: 0001755469 (see all company filings)

IRS No.: 000000000
Type: DFAN14A